Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Sep-24 5:11 PM View:  | Akero Therapeutics, Inc. (AKRO) | 10-Sep-24 | Private Sale | 537 | $26.18 | $14,058.70 | (< 1%) 181.24K to 180.71K | |
| 13-Jun-24 6:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 11-Jun-24 | Private Sale | 2,380 | $22.64 | $53,885.60 | (1%) 182.56K to 180.18K | |
| 15-Mar-24 4:42 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Mar-24 | Private Sale | 619 | $28.33 | $17,536.30 | (< 1%) 183.18K to 182.56K | |
| 18-Dec-23 8:29 PM View: | Akero Therapeutics, Inc. (AKRO) | 14-Dec-23 | Market Sale | 514 | $20.76 | $10,670.60 | (< 1%) 183.19K to 182.67K | 5% |
| 12-Dec-23 4:38 PM View: | Akero Therapeutics, Inc. (AKRO) | 08-Dec-23 | Grant | 32,497 | -- | -- | 22% 150.69K to 183.19K | |
| 25-Sep-23 8:30 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Sep-23 | Private Sale (Planned) | 531 | $50.34 | $26,730.50 | (< 1%) 151.22K to 150.69K | |
| 21-Jun-23 5:46 PM View: | Akero Therapeutics, Inc. (AKRO) | 16-Jun-23 | Option Exercise | 40,000 | $0.61 | $24,400.00 | 21% 189.42K to 229.42K | |
| 21-Jun-23 5:46 PM View: | Akero Therapeutics, Inc. (AKRO) | 16-Jun-23 | Option Sale | 40,000 | $54.78 | $2,191,340.00 | (17%) 229.42K to 189.42K | |
| 21-Jun-23 5:46 PM View: | Akero Therapeutics, Inc. (AKRO) | 16-Jun-23 | Sale | 38,200 | $54.78 | $2,092,730.00 | (20%) 189.42K to 151.22K | |
| 15-Jun-23 9:35 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Jun-23 | Private Sale (Planned) | 509 | $55.16 | $28,076.40 | (< 1%) 189.93K to 189.42K | |
| 14-Mar-23 4:19 PM View: | Akero Therapeutics, Inc. (AKRO) | 10-Mar-23 | Payment of Exercise | 603 | $43.47 | $26,212.40 | (< 1%) 190.53K to 189.93K | |
| 30-Dec-22 4:26 PM View: | Akero Therapeutics, Inc. (AKRO) | 29-Dec-22 | Option Exercise | 7,816 | $28.35 | $221,584.00 | 4% 203.03K to 210.85K | |
| 30-Dec-22 4:26 PM View: | Akero Therapeutics, Inc. (AKRO) | 29-Dec-22 | Planned Option Sale | 7,816 | $51.05 | $399,002.00 | (4%) 210.85K to 203.03K | |
| 30-Dec-22 4:26 PM View: | Akero Therapeutics, Inc. (AKRO) | 29-Dec-22 | Sale (Planned) | 12,500 | $51.05 | $638,117.00 | (6%) 203.03K to 190.53K | |
| 30-Dec-22 4:26 PM View: | Akero Therapeutics, Inc. (AKRO) | 28-Dec-22 | Option Exercise | 1,700 | $28.35 | $48,195.00 | < 1% 203.03K to 204.73K | |
| 30-Dec-22 4:26 PM View: | Akero Therapeutics, Inc. (AKRO) | 28-Dec-22 | Planned Option Sale | 1,700 | $50.00 | $85,006.50 | (< 1%) 204.73K to 203.03K | |
| 13-Dec-22 8:30 PM View: | Akero Therapeutics, Inc. (AKRO) | 09-Dec-22 | Grant | 19,195 | -- | -- | 10% 183.84K to 203.03K | |
| 16-Nov-22 7:15 PM View: | Akero Therapeutics, Inc. (AKRO) | 16-Nov-22 | Sale (Planned) | 3,947 | $45.47 | $179,464.00 | (2%) 187.78K to 183.84K | |
| 16-Nov-22 7:15 PM View: | Akero Therapeutics, Inc. (AKRO) | 15-Nov-22 | Private Sale (Planned) | 3,138 | $45.04 | $141,343.00 | (2%) 190.92K to 187.78K | |
| 27-Oct-22 9:27 PM View: | Akero Therapeutics, Inc. (AKRO) | 26-Oct-22 | Sale (Planned) | 4,762 | $45.03 | $214,433.00 | (2%) 195.68K to 190.92K | |
| 27-Oct-22 9:27 PM View: | Akero Therapeutics, Inc. (AKRO) | 25-Oct-22 | Option Exercise | 10,000 | $10.31 | $103,116.00 | 5% 196.34K to 206.34K | |
| 27-Oct-22 9:27 PM View: | Akero Therapeutics, Inc. (AKRO) | 25-Oct-22 | Planned Option Sale | 10,000 | $45.09 | $450,905.00 | (5%) 206.34K to 196.34K | |
| 27-Oct-22 9:27 PM View: | Akero Therapeutics, Inc. (AKRO) | 25-Oct-22 | Sale (Planned) | 653 | $45.09 | $29,444.10 | (< 1%) 196.34K to 195.68K | |
| 07-Oct-22 6:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 06-Oct-22 | Option Exercise | 10,000 | $21.09 | $210,900.00 | 5% 198.84K to 208.84K | (7%) |
| 07-Oct-22 6:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 06-Oct-22 | Planned Private Option Sale | 10,000 | $39.29 | $392,900.00 | (5%) 208.84K to 198.84K | |
| 07-Oct-22 6:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 06-Oct-22 | Sale (Planned) | 12,500 | $39.29 | $491,125.00 | (6%) 198.84K to 186.34K | |
| 04-Oct-22 8:57 PM View: | Akero Therapeutics, Inc. (AKRO) | 30-Sep-22 | Option Exercise | 20,000 | $16.43 | $328,589.00 | 9% 223.84K to 243.84K | |
| 04-Oct-22 8:57 PM View: | Akero Therapeutics, Inc. (AKRO) | 30-Sep-22 | Planned Option Sale | 20,000 | $32.72 | $654,400.00 | (8%) 243.84K to 223.84K | |
| 04-Oct-22 8:57 PM View: | Akero Therapeutics, Inc. (AKRO) | 30-Sep-22 | Sale (Planned) | 25,000 | $32.72 | $818,000.00 | (11%) 223.84K to 198.84K | |
| 15-Sep-22 7:56 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Sep-22 | Private Sale (Planned) | 22,500 | $29.18 | $656,550.00 | (9%) 246.34K to 223.84K | |
| 13-Sep-22 9:14 PM View: | Akero Therapeutics, Inc. (AKRO) | 30-Jun-22 | Grant | 1,152 | $8.03 | $9,250.56 | < 1% 245.19K to 246.34K | |
| 13-Sep-22 9:14 PM View: | Akero Therapeutics, Inc. (AKRO) | 30-Jun-21 | Grant | 1,007 | $21.09 | $21,237.60 | < 1% 244.18K to 245.19K | |
| 09-Dec-20 8:49 PM View: | Akero Therapeutics, Inc. (AKRO) | 30-Jun-20 | Grant | 1,245 | $17.07 | $21,249.70 | < 1% 242.93K to 244.18K | |
| 13-Mar-20 7:04 PM View: | Akero Therapeutics, Inc. (AKRO) | 12-Mar-20 | Option Exercise | 50,024 | $0.61 | $30,514.60 | 26% 192.91K to 242.93K |